Literature DB >> 12791179

High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells.

Feng Hao1, Jin-De Yu.   

Abstract

AIM: To investigate the effects of high glucose on expression of matrix metalloproteinase-2 (MMP-2) in rat aortic smooth muscle cells and the influence of matrix remodeling on atherogenesis in diabetic patients.
METHODS: The smooth muscle cells were cultured from the thoracic aorta of Sprague-Dawley (SD) rat. MMP-2 mRNA was determined by reverse transcriptase-polymerase chain reaction (RT-PCR), MMP-2 protein was measured by Western blotting, and MMP-2 activity in conditioned medium was observed by zymography.
RESULTS: In comparison with the control, there was no difference in the expression of MMP-2 when glucose concentration was 1 g/L, whereas MMP-2 activity in smooth muscle cells was significantly increased by the glucose 5 g/L (P<0.01).
CONCLUSION: High glucose enhanced the expression and activity of MMP-2 in smooth muscle cells, which may provide an explanation for the phenomenon that diabetes patients are prone to have atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791179

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice.

Authors:  S Givvimani; U Sen; N Tyagi; C Munjal; S C Tyagi
Journal:  Arch Physiol Biochem       Date:  2010-09-14       Impact factor: 4.076

2.  Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats.

Authors:  Lokesh Kumar Bhatt; Veeranjaneyulu Addepalli
Journal:  Am J Transl Res       Date:  2010-02-12       Impact factor: 4.060

3.  Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Authors:  Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen F Kemp; John L Fowlkes
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

Review 4.  Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.

Authors:  Kathryn M Thrailkill; R Clay Bunn; John L Fowlkes
Journal:  Endocrine       Date:  2008-10-30       Impact factor: 3.633

5.  MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.

Authors:  Wiktor Kuliczkowski; Marek Radomski; Mariusz Gąsior; Joanna Urbaniak; Jacek Kaczmarski; Andrzej Mysiak; Marta Negrusz-Kawecka; Iwona Bil-Lula
Journal:  Biomed Res Int       Date:  2017-07-10       Impact factor: 3.411

6.  High glucose concentration up-regulates the expression of matrix metalloproteinase-9 and -13 in tendon cells.

Authors:  Wen-Chung Tsai; Fang-Chen Liang; Ju-Wen Cheng; Li-Ping Lin; Shih-Chieh Chang; Hsiang-Hung Chen; Jong-Hwei S Pang
Journal:  BMC Musculoskelet Disord       Date:  2013-08-27       Impact factor: 2.362

7.  Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study.

Authors:  Wiktor Kuliczkowski; Marta Banaszkiewicz; Andrzej Mysiak; Grzegorz Makaś; Iwona Bil-Lula
Journal:  Cardiol Res Pract       Date:  2019-11-04       Impact factor: 1.866

8.  Hyperglycemia-Induced Modulation of the Physiognomy and Angiogenic Potential of Fibroblasts Mediated by Matrix Metalloproteinase-2: Implications for Venous Stenosis Formation Associated with Hemodialysis Vascular Access in Diabetic Milieu.

Authors:  Rajiv Janardhanan; Sreenivasulu Kilari; Edward B Leof; Sanjay Misra
Journal:  J Vasc Res       Date:  2016-03-18       Impact factor: 1.934

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.